Philips Receives FDA Clearance for Breakthrough SmartSpeed Precise in AI-Powered MRI

Philips has gained FDA 510(k) clearance for its latest deep learning-based software, SmartSpeed Precise, designed to improve MRI performance. This approval marks a significant development towards more personalised and autonomous MRI imaging.

SmartSpeed Precise is the first dual artificial intelligence (AI) solution in the MRI market. It allows scans to be up to three times faster and images up to 80% sharper, all through a simplified, single-click process. 

The software is now approved for use across all Philips 1.5T and 3.0T MRI systems, including existing installations, making it one of the most widely scalable innovations currently available in MRI technology.

With rising global demand for MRI services and ongoing staffing shortages, healthcare providers are under increasing pressure to manage growing waiting lists while maintaining high diagnostic standards. 

Philips’ SmartSpeed Precise is aimed at addressing these challenges by offering faster, more efficient scans without compromising image quality.

The technology integrates three core components into one seamless system, such as compressed SENSE, Philips’ established image acceleration tool, an AI-driven denoising engine that reduces visual noise for clearer images, and a second AI model focused on sharpening images and reducing visual artefacts.

This dual AI integration supports faster scanning and better diagnostic clarity across clinical environments. By simplifying workflows and reducing the need for manual adjustments, the system helps radiology departments operate more efficiently, even with limited staffing.

By integrating powerful AI tools directly into MRI systems, Philips continues to support healthcare providers in managing increasing demand while improving patient outcomes and maintaining high imaging standards.